• Final NHS green light for Amgen’s Kyprolis pharmatimes
    July 21, 2017
    Patients living with multiple myeloma across England and Wales should now get ‘routine’ access to Amgen’s Kyprolis on the NHS within three months following a final green light from the National Institute for Health and Care Excellence.
PharmaSources Customer Service